Nothing Special   »   [go: up one dir, main page]

PL2794849T3 - Sposób wytwarzania wysokowydajnych atenuowanych szczepów Salmonella - Google Patents

Sposób wytwarzania wysokowydajnych atenuowanych szczepów Salmonella

Info

Publication number
PL2794849T3
PL2794849T3 PL12808264T PL12808264T PL2794849T3 PL 2794849 T3 PL2794849 T3 PL 2794849T3 PL 12808264 T PL12808264 T PL 12808264T PL 12808264 T PL12808264 T PL 12808264T PL 2794849 T3 PL2794849 T3 PL 2794849T3
Authority
PL
Poland
Prior art keywords
high yield
producing high
attenuated salmonella
salmonella strains
yield attenuated
Prior art date
Application number
PL12808264T
Other languages
English (en)
Inventor
Heinz Lubenau
Holger Siede
Renate Janssen
Marco Springer
Original Assignee
Vaximm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaximm Ag filed Critical Vaximm Ag
Publication of PL2794849T3 publication Critical patent/PL2794849T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/001102Receptors, cell surface antigens or cell surface determinants
    • A61K39/001103Receptors for growth factors
    • A61K39/001109Vascular endothelial growth factor receptors [VEGFR]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q3/00Condition responsive control processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL12808264T 2011-12-22 2012-12-21 Sposób wytwarzania wysokowydajnych atenuowanych szczepów Salmonella PL2794849T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11400061 2011-12-22
PCT/EP2012/005364 WO2013091898A1 (en) 2011-12-22 2012-12-21 Method for producing high yield attenuated salmonella strains
EP12808264.1A EP2794849B1 (en) 2011-12-22 2012-12-21 Method for producing high yield attenuated salmonella strains

Publications (1)

Publication Number Publication Date
PL2794849T3 true PL2794849T3 (pl) 2018-02-28

Family

ID=47458857

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12808264T PL2794849T3 (pl) 2011-12-22 2012-12-21 Sposób wytwarzania wysokowydajnych atenuowanych szczepów Salmonella

Country Status (20)

Country Link
US (1) US9493738B2 (pl)
EP (1) EP2794849B1 (pl)
JP (1) JP6251179B2 (pl)
KR (1) KR102015932B1 (pl)
CN (1) CN104066834B (pl)
AU (1) AU2012359166B2 (pl)
BR (1) BR112014015706A2 (pl)
CA (1) CA2853656C (pl)
DK (1) DK2794849T3 (pl)
ES (1) ES2650269T3 (pl)
HU (1) HUE035438T2 (pl)
IL (1) IL233167A (pl)
LT (1) LT2794849T (pl)
MX (1) MX355134B (pl)
PL (1) PL2794849T3 (pl)
RU (1) RU2631924C2 (pl)
SG (1) SG11201403525PA (pl)
SI (1) SI2794849T1 (pl)
WO (1) WO2013091898A1 (pl)
ZA (1) ZA201404501B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE046138T2 (hu) 2012-07-05 2020-02-28 Vaximm Ag DNS vakcina hasnyálmirigyrákos betegekben történõ alkalmazásra
CA2932388A1 (en) * 2013-12-18 2015-06-25 Vaximm Gmbh Novel msln targeting dna vaccine for cancer immunotherapy
SI3310379T1 (sl) 2015-06-18 2020-02-28 Vaximm Ag DNA cepivo, ki cilja VEGFR-2, za kombinacijsko terapijo
US20180153976A1 (en) 2015-06-18 2018-06-07 Vaximm Ag Novel cmv pp65 targeting dna vaccine for cancer immunotherapy
KR20230079514A (ko) * 2016-07-13 2023-06-07 엔이씨 온코이뮤니티 에이에스 암 면역요법용 dna 백신을 제조하기 위한 방법
CA3050833A1 (en) 2017-02-17 2018-08-23 Vaximm Ag Novel vegfr-2 targeting immunotherapy approach
WO2020205528A1 (en) * 2019-04-01 2020-10-08 North Carolina State University Probiotic bacteria capable of adaptive response to pomegranate extract and methods of production and use thereof
JP2023519562A (ja) 2020-03-31 2023-05-11 エンエーセー オンコイミュニティ アクスイェ セルスカプ サルモネラに基づく新規コロナウイルスワクチン

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH542928A (de) * 1971-04-29 1973-10-15 Schweiz Serum & Impfinst Verfahren zur Herstellung einer neuen Typhus-Vakzine
KR930001382B1 (ko) * 1990-09-05 1993-02-27 보령신약 주식회사 경구용 장티프스 생균백신 및 그의 제조방법
WO2002053180A2 (en) * 2001-01-03 2002-07-11 Willmar Poultry Company, Inc. Immunizing compositions and methods of use
US7094410B2 (en) 2002-03-02 2006-08-22 The Scripps Research Institute DNA vaccine against proliferating endothelial cells and methods of use thereof
EP1670505B1 (en) * 2003-09-18 2012-11-14 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Dna promoters and anthrax vaccines
WO2010045620A1 (en) * 2008-10-17 2010-04-22 The Arizona Board Of Regents For And On Behalf Of Arizona State University Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae
CN101985610A (zh) * 2010-10-26 2011-03-16 中国人民解放军军事医学科学院微生物流行病研究所 一种伤寒沙门氏菌菌蜕、制备方法及作为递送系统的应用

Also Published As

Publication number Publication date
WO2013091898A1 (en) 2013-06-27
SI2794849T1 (en) 2018-01-31
BR112014015706A2 (pt) 2020-10-27
ES2650269T3 (es) 2018-01-17
IL233167A0 (en) 2014-07-31
CN104066834A (zh) 2014-09-24
EP2794849A1 (en) 2014-10-29
DK2794849T3 (da) 2017-11-06
JP6251179B2 (ja) 2017-12-20
CA2853656A1 (en) 2013-06-27
AU2012359166B2 (en) 2017-08-10
MX355134B (es) 2018-04-06
MX2014007575A (es) 2015-02-05
EP2794849B1 (en) 2017-08-30
US20140349274A1 (en) 2014-11-27
KR102015932B1 (ko) 2019-08-29
KR20140105028A (ko) 2014-08-29
WO2013091898A8 (en) 2015-03-12
ZA201404501B (en) 2016-02-24
AU2012359166A1 (en) 2014-06-19
IL233167A (en) 2017-08-31
HUE035438T2 (en) 2018-05-02
US9493738B2 (en) 2016-11-15
RU2631924C2 (ru) 2017-09-28
CN104066834B (zh) 2017-04-19
JP2015502162A (ja) 2015-01-22
RU2014130045A (ru) 2016-02-10
SG11201403525PA (en) 2014-10-30
LT2794849T (lt) 2017-12-11
CA2853656C (en) 2020-12-29

Similar Documents

Publication Publication Date Title
IL263389B (en) A method for the production of modified 5-fluoro-1h-pyrazolopyridines
ZA201401133B (en) Method for producing ternesite
EP2743336A4 (en) PROCESS FOR THE PRODUCTION OF HIGH-PURITY BIODIESEL
EP2699534A4 (en) PROCESS FOR PRODUCING TRANS-1233zd
HK1188090A1 (en) Method for producing instant noodles
ZA201404501B (en) Method for producing high yield attenuated salmonella strains
EP2740719A4 (en) PROCESS FOR THE PREPARATION OF A-FLUOROALDEHYDE
EP2757087A4 (en) PROCESS FOR THE PRODUCTION OF BIODIESEL
HK1218912A1 (zh) 製造神經氨酸衍生物的方法
EP2784063A4 (en) PROCESS FOR THE PREPARATION OF BETA-MERCAPTOCARBONIC ACID
IL231877A0 (en) A method for the production of dithiene tetracarboximides
EP2674421A4 (en) PROCESS FOR THE PREPARATION OF 2-FURALDEHYDE
IL231878A0 (en) A method for the production of dithiene tetracarboximides
EP2754717A4 (en) PROCESS FOR PRODUCTION OF POLYHYDROXYALCANOATE HAVING MAIN CHAIN STRUCTURE
HK1197716A1 (zh) 布丁的製造方法
HUP1100224A2 (en) Process for producing of fruit fine-rot
EP2784064A4 (en) PROCESS FOR PRODUCTION OF BETA-MERCAPTOCARBOXYLIC ACID